Stock getting killed again!

[anonymous]

Newsflash Moron, the market is crashing. High tech high science biotech has really gotten hammered, but Esperion has held up well. Losers always complain, winners look forward and find a way to win. The technical pattern coupled with the sheer compelling business/scientific outlook make this a no brainer.

 

[anonymous]

Newsflash Moron, the market is crashing. High tech high science biotech has really gotten hammered, but Esperion has held up well. Losers always complain, winners look forward and find a way to win. The technical pattern coupled with the sheer compelling business/scientific outlook make this a no brainer.

Yes a "no brainer" indeed.

 

[anonymous]

Now it's the technical pattern . Was it the technical pattern when the the stock was $78.00. When it was $78.00 big tech was doing well. Just accept thi is a dud with a pathetic plan and the worst launch in pharma in 10 years. This couldn'tnof gone worse. Your management colleagues are castoffs from other companies and could screw up a face- painting party for 5 yesr olds. Very embarassing what this company has accomplished since Feb of 2020. $4.83 is pathetic. This stock has been hovering in $4 to $5 range for months. Where is the techincal pattern? Is this the same as runway, uptick , etc. Please explain your business acumen so us laymen can understand how a stock can be down 90% in two years. We're waiting for the technical pattern.

 

[anonymous]

Let’s just pretend you are a carton character and you got run over by a steamer roller. You are a flat, this equates to your non hire. Then miraculously you get up and you maintain several years of vendetta against the lipid experts… only to be flattened again. Looser.

 

[anonymous]

Who are the lipid experts? You mean those stellar hires at the start that lasted 6 months with shitty sales? Or how about the inept RSM's that completely botched the hire process. Seems like a great bunch of losers were involved with this cluster fuck launch. Embarassing that some Ann Arbor twit thinks he's a lipid expert.

 

[anonymous]

Finally high tech bioscience is getting a bid in the market, and Esperion is clearly a leader. Technical patterns and charts don’t lie, coupled with a compelling business rationale, this really sets up for a great second half of the year, look for a double before January

 

[anonymous]

Finally high tech bioscience is getting a bid in the market, and Esperion is clearly a leader. Technical patterns and charts don’t lie, coupled with a compelling business rationale, this really sets up for a great second half of the year, look for a double before January

A hope you go to jail for your insider deception toward investors

 

[anonymous]

Well this is a banner day for Esperion . Esperion officially got to $6.00 a share. After a year of bathtub farting and doing nothing the stock just took a monumental jump to $6.00 a share. Now $70.00 more to go. Great job Sheldon.

 

[anonymous]

Now back to $5.93. No uptick or runway or ladder or correctional shift.